New Transfection Systems Tackle Delivery Issues and Off-Target Effects Will RNAi-based therapeutics provide the next class of blockbuster drugs? If pharma’s acquisition spree of companies with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback